Review paper on prophylaxis in children with haemophilia

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Review paper on prophylaxis in children with haemophilia

Prof. Karin Fijnvandraat, Prof. Christoph Male, Prof. Christoph Königs, Prof. Gili Kenet, Assoc. Prof. Jan Blatný, Dr Maria Elisa Mancuso, Prof. Kaan Kavakli

The Hemostasis CONNECT European Collaborative Haemophilia Network (ECHN) Group is proud to announce publication of the review paper: Prophylaxis in children with haemophilia in an evolving treatment landscape.

Prof. Karin Fijnvandraat

Paediatric Haematologist

University of Amsterdam

Netherlands

Prof. Christoph Male

Paediatric Haematologist

Medical University of Vienna

Austria

Prof. Christoph Königs

Paediatric Haematologist

University Hospital Frankfurt

Germany

Prof. Gili Kenet

Haematologist

National Hemophilia Center and Thrombosis Institute in Tel Hashom...

Israel

Assoc. Prof. Jan Blatný

Paediatric Haematologist

Children's University Hospital Brno

Czech Republic

Dr Maria Elisa Mancuso

Haematologist

Center of Thrombosis and Hemorrhagic Diseases of Humanitas Clinic...

Italy

Prof. Kaan Kavakli

Paediatric Haematologist

Ege University

Turkey

Prof. Christoph Male

Paediatric Haematologist

Medical University of Vienna

Austria

Christoph Male is consultant and associate professor at the Department of Paediatrics, Medical University of Vienna (MUW), Austria, where he heads the Paediatric Haemostasis & Thrombosis unit. He trained in General Medicine and Paediatrics, with sub-speciality degrees in Paediatric Cardiology and Paediatric Intensive Care. He was clinical and research fellow with the Paediatric Thrombophilia Programme at the Hospital for Sick Children, Toronto, and McMaster University, Hamilton, Ontario, Canada, where he also earned a M.Sc. degree in Health Research Methodology (1998-2000). Dr Male’s scientific interest is in paediatric haemostasis & thrombosis, anticoagulation, clinical pharmacology, drug evaluation and clinical trials methodology in children. He has more 20 years of experience in clinical research and is actively involved in several academic or industry-sponsored clinical trials in children. Dr Male currently acts as co-chair of the Paediatric Scientific and Standardization Subcommittee of the International Society of Thrombosis & Haemostasis (ISTH), chair of the Scientific Board of the Austrian Haemophilia Society, and past board member of the German-Austrian-Swiss Society of Thrombosis and Haemostasis Research (GTH). He served as Austrian delegate in the Paediatric Committee (PDCO) at the European Medicines Agency from 2007-2016, is a member of the Scientific Board of the Austrian Medicines Agency and paediatric member of the ethics committee of the MUW

Prof. Christoph Königs

Paediatric Haematologist

University Hospital Frankfurt

Germany

Christoph Königs has been based at the Paediatric Haemophilia Centre, University Hospital Frankfurt, Germany since 2002. He received his degree in science from Monash University, Melbourne, Australia in 1998 and his medical degree from Goethe University Frankfurt, Germany in 2002. For both his MD and PhD thesis, Christoph isolated ligands to clinically relevant structures of protein receptors and RNA. The main clinical and scientific interest of his research team is the understanding and modification of the immune response to coagulations factors. His main clinical focus is developing and improving therapies for children and adolescents with coagulation disorders with a focus on patient education and shared decision making. Christoph specialises in paediatrics and adolescent medicine and also in haemostasis. He is a member of several national and international scientific societies and committees. He co-chairs the Standing Committee Haemophilia of the Society for Thrombosis and Haemostasis (GTH), the National Registry on PUPs with Newly Diagnosed Haemophilias in Germany “GEPHARD” and the Scientific Advisory Council of PedNet. Christoph works closely with German patient organizations i.e. as a deputy chair of the medical advisory board.

Biography Disclosures

Prof. Gili Kenet

Haematologist

National Hemophilia Center and Thrombosis Institute in Tel Hashomer and Amalia Biron Thrombosis Research Institute of Tel Aviv University

Israel

Director of the Israel National Haemophilia Centre and Thrombosis Institute, Sheba Medical Centre and Director of Amalia Biron Research Institute of Thrombosis and Haemostasis, Tel Aviv University (located at the Sheba Medical Centre). Gili Kenet is a paediatric haematologist, Professor and former Chair of the Haematology Department at the Sackler Medical School, Tel Aviv University. Professor Kenet received her Medical Degree from the Hebrew University in Jerusalem. Her research projects have been focused on neonatal haemostasis, childhood stroke and paediatric thrombophilia, as well as the research of new therapy modes applied for people with haemophilia and severe bleeding disorders. She was awarded national grants for paediatric haematology and cancer research, study of rFVIIa mode of action, epidemiology of inhibitor evolution in haemophilia and for personalised tailoring of bypass agent therapy, and applying global haemostasis assays. Prof. Kenet pioneered in gene therapy clinical trials in Israel and novel non replacement drugs in haemophilia. Professor Kenet is the author of over 200 peer reviewed scientific publications, review articles and book chapters. An active member of the World Federation of Haemophilia, Israeli Society of Paediatric Haematology and Oncology, and the American Society of Haematology, an active reviewer for high impact thrombosis journals and an editorial board member of the Haemophilia journal. Former Chairperson of the Israeli Society of Thrombosis and Haemostasis and Chairperson of the Paediatric and Peri-natal Haemostasis Scientific Subcommittee of ISTH. Currently co-chairs the FVIII/FIX and rare bleeding disorders of the SSC of ISTH.

Prof. Gili Kenet has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, Biomarin, CSL, Novo Nordisk, Pfizer, Roche, Sanofi, Takeda and Uniquore.

Biography Disclosures

Assoc. Prof. Jan Blatný

Paediatric Haematologist

Children's University Hospital Brno

Czech Republic

Jan Blatný, MD, PhD, is Consultant Haematologist at the Department of Paediatric Haematology and Biochemistry, Centre for Thrombosis and Haemostasis and the Director of the Haemophilia Comprehensive Care Centre of University Hospital in Brno, Czech Republic. He is also an Associate Professor of Paediatrics at Masaryk University in Brno, Czech Republic. His research interests encompass paediatric haematology, thrombosis and haemostasis, and life-threatening bleeding. He is a member of the Working Party on population PK of the ISTH SSC Subcommittee on Factor VIII and IX and Rare Bleeding Disorders. In addition to ISTH, Dr Blatný is a member of numerous national and international haematology organizations. He serves on the steering committee and is a paediatric coordinator of the Czech National Haemophilia Programme, Vice-president and a member of Executive Committee of EAHAD, member of MAG (Medical advisory group) of EHC, a reviewer for several haematology journals, and is on the editorial board for an official journal of Czech Haematology society. Dr Blatný’s publication credits are 9 book chapters and over 100 articles published in peer-reviewed journals

Assoc. Prof. Jan Blatný has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Novo Nordisk, Pfizer, Roche, Sobi and Takeda.

Biography Disclosures

Dr Maria Elisa Mancuso

Haematologist

Center of Thrombosis and Hemorrhagic Diseases of Humanitas Clinical and Research Center (IRCCS)

Italy

Maria Elisa Mancuso MD, PhD is a Senior Consultant in Haematology with a special interest in haemostasis. She obtained a post-degree in Clinical and Experimental Haematology and a PhD in Clinical Methodology. She worked as a Clinical Assistant at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center in Milan (Italy) from 2008 to 2020. Since May 2020 she has been Senior Consultant at the Center for Thrombosis and Haemorrhagic Diseases at IRCCS Humanitas Research Center in Rozzano, Milan (Italy). Dr Mancuso is involved in clinical research and has published several original articles in peer-reviewed journals such as The Lancet, Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology and Haemophilia. She is a member of the Editorial Board of the Journal of Thrombosis and Haemostasis and is a reviewer for several peer-reviewed journals in the field of Thrombosis and Haemostasis and is a member of several national and international scientific societies (AICE, SISET, ISTH, WFH, ASH, EAHAD). She has acted as Co-Chair of the Scientific and Standardization Subcommittee of ISTH (SSC-ISTH) on FVIII, FIX and rare bleeding disorders. Dr Mancuso has been involved as co-investigator in several clinical trials, and takes care of both children and adults with haemophilia with a specific scientific interest in inhibitors, chronic hepatitis C, optimisation of prophylaxis and novel therapies.

Dr Maria Elisa Mancuso has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, Biomarin, Bioscience, Catalyst, CSL Behring, Novo Nordisk, Octopharma, Pfizer, Grifols, Kedrion, LFB, Roche, Sanofi, Sobi, Takeda, Spark Therapeutic and UniQure.

Biography Disclosures

Prof. Kaan Kavakli

Paediatric Haematologist

Ege University

Turkey

Kaan Kavakli, MD, is chair of the Department of Paediatrics and a professor of paediatrics and paediatric haematology at the Medical School of Ege University in Izmir, Turkey, where he previously was chair of the Department of Paediatric Haematology. Additionally, he is a paediatric haematologist in the Department of Paediatrics at Ege University Hospital and the director of the Ege Haemophilia Centre and the Ege Haemophilia Association. Dr Kavakli received his medical degree and training in paediatrics at Ege University Medical School. His special interests are haemostasis, thrombosis, and the care of patients with haemophilia. His recent work has included identification of certain mutations in Turkish haemophilia patients with inhibitors, radioisotope synovectomy for haemophilic arthropathy, the role of circumcision in boys with haemophilia, and treatment options for patients with inhibitors. Dr Kavakli has been a principal investigator for international clinical trials in haemophilia. Dr Kavakli is president of the Turkish Hemostasis and Thrombosis Association and the Hemophilia Federation of Turkey, which comprises 11 regional haemophilia associations. He is a member of many international societies and serves on the editorial boards and as a reviewer for several haematology journals. Dr Kavakli has published more than 100 papers in such journals as Blood, The New England Journal of Medicine, and Haemophilia, etc.

Prof. Kaan Kavakli has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, Novo Nordisk, Roche and Takeda.

time | open 5 min | Sep 2021

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

Download slides PDF

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

This paper is published in the journal Haemophilia and is authored by ECHN members Dr. Maria Elisa Mancuso (Italy), Prof. Christoph Male (Austria), Prof. Gili Kenet (Israel), Dr. Kaan Kavakli (Turkey), Dr. Christoph Königs (Germany), Prof. Jan Blatný (Czech Republic) and Prof. Karin Fijnvandraat (The Netherlands). Based on literature and practical experience, the authors discuss when to start prophylaxis in young children, the pros and cons of the products available and practical aspects of starting prophylaxis to guide the choice of regimen.

View the e publication here. Download the slides for a summary of the key highlights.

HEMOSTASIS CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Takeda, Viatris and Sobi.

Other programmes of interest

Prof. Pål Andrè Holme

Prof. Niamh O'Connell

Assoc. Prof. Jan Blatný

E-learning

35 min

Accreditation: EACCME

Normalising Haemostasis in Haemophilia: Panel Discussion and E-le...

Sep 2023

Prof. Dimitrios Tsakiris

Prof. Michael Nagler

Podcast

20 min

Monitoring Anticoagulation: Yes or No?

Aug 2023

Dr Vickie McDonald

Prof. Ana Boban

Video

4 min

How Coagulation Cascade Deficiencies Lead to Bleeding Disorders

Jul 2023

Dr Ayesha Zia

Prof. Rezan Abdul-Kadir

Dr Michelle Lavin

Video

3 min

Iron Deficiency in Women and Girls with Bleeding Disorders

Apr 2023

Dr Sarah O'Brien

Debra Pollard

Dr. Homa K. Ahmadzia

Video

23 min

Video: Women with Bleeding Disorders - A lifelong journey

Apr 2023

Assoc. Prof. Jan Blatný

Dr Michael A Mazzeffi

E-learning

30 min

Von Willebrand Disease Emergency Care: An Interactive Patient Cas...

Mar 2023

Dr Sarah O'Brien

Dr. Homa K. Ahmadzia

Podcast

20 min

Podcast: Gynaecological Considerations in Women with Bleeding Dis...

Jan 2023

Dr Roseline d'Oiron

Dr Michelle Lavin

Podcast

20 min

Podcast: Iron Deficiency in Women with Bleeding Disorders

Nov 2022

Prof. Ana Boban

Dr Jonathan C. Roberts

Podcast

20 min

Podcast: Treating von Willebrand Disease: Does the Type Matter?

Nov 2022

Prof. Rezan Abdul-Kadir

Debra Pollard

Podcast

22 min

Podcast: Bleeding Disorders and Pregnancy

Sep 2022

Prof. Jerzy Windyga

Prof. Cedric Hermans

Podcast

20 min

Podcast: changing paradigms of haemophilia care in Europe

Aug 2022

Dr Vickie McDonald

Dr Rosa Sonja Alesci

Assoc. Prof. Alison Dougall

Dr Michael A Mazzeffi

And others...

60 min

Accreditation: EACCME

Von Willebrand Disease: Recognising, Screening and Impact

Jun 2022

Other programmes developed by Assoc. Prof. Jan Blatný

Assoc. Prof. Jan Blatný

Paediatric Haematologist

Children's University Hospital Brno

Czech Republic

Prof. Pål Andrè Holme

Prof. Niamh O'Connell

Assoc. Prof. Jan Blatný

E-learning

35 min

Accreditation: EACCME

Normalising Haemostasis in Haemophilia: Panel Discussion and E-le...

Sep 2023

Assoc. Prof. Jan Blatný

Dr Michael A Mazzeffi

E-learning

30 min

Von Willebrand Disease Emergency Care: An Interactive Patient Cas...

Mar 2023

Dr Vickie McDonald

Dr Rosa Sonja Alesci

Assoc. Prof. Alison Dougall

And others...

60 min

Accreditation: EACCME

Von Willebrand Disease: Recognising, Screening and Impact

Jun 2022

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.